The present invention relates to the use of compounds for imparting a temperature regulating effect to a textile and methods of manufacturing a temperature regulating textile. The present invention also relates to a method of manufacturing a temperature regulating textile, wherein the textile forms part of a non-apparel article. Compounds for imparting a temperature regulating effect on a textile are also described.

The present invention relates to the use of compounds for imparting a temperature regulating effect to a textile and methods of manufacturing a temperature regulating textile. The present invention also relates to a method of manufacturing a temperature regulating textile, wherein the textile forms part of a non-apparel article. Compounds for imparting a temperature regulating effect on a textile are also described.

A multi-coat coating system having an undercoat composition and an overcoat composition, wherein the undercoat, overcoat or both the undercoat and overcoat contain a polymer having segments of a specified formula and are substantially free of polyhydric phenols having estrogenic activity greater than or equal to that of bisphenol S. The coating system is suitable for use on a food-contact surface of food or beverage containers.

A PEG linker as represented by formula (I), wherein n and m are respectively an integer from 1 to 7, providing the PEG linker with 1 to 49 linking sites. A ligand drug conjugate as represented by formula (II). The conjugate uses the PEG linker to increase a drug loading capacity and drug loading diversity, thereby improving pharmaceutical efficacy.
Y1-PEG1-{R.sup.1-PEG2-{Y4}.sub.n}.sub.m  (I)
TM-{R.sup.2-PEG1-{R.sup.1-PEG2-{R.sup.3-A′-drug}.sub.n}.sub.m}.sub.l  (II)

A PEG linker as represented by formula (I), wherein n and m are respectively an integer from 1 to 7, providing the PEG linker with 1 to 49 linking sites. A ligand drug conjugate as represented by formula (II). The conjugate uses the PEG linker to increase a drug loading capacity and drug loading diversity, thereby improving pharmaceutical efficacy.
Y1-PEG1-{R.sup.1-PEG2-{Y4}.sub.n}.sub.m  (I)
TM-{R.sup.2-PEG1-{R.sup.1-PEG2-{R.sup.3-A′-drug}.sub.n}.sub.m}.sub.l  (II)

Provided are a polymer represented by Formula 1, an electrolyte including the same, and a lithium battery including the polymer.

Provided are a polymer represented by Formula 1, an electrolyte including the same, and a lithium battery including the polymer.

A polyarylether-based polymer with side chain in polyethylene glycol structure, a solid polymer electrolyte and preparation methods therefor are disclosed. The main chain of the polymer has a polymer structure containing a polyarylether group, the side chain has a polyethylene glycol structure, and the structural formula of the polyarylether-based polymer is as follows:

##STR00001##

and the preparation method for the polyarylether-based polymer with side chain in polyethylene glycol structure comprises: step (1): preparing a polymer containing a polyarylether group; and step (2): dissolving the polymer containing a polyarylether group and polyethylene glycol in a solvent, then adding a catalyst, dripping a coupling agent after the catalyst is dissolved, and conducting reaction while stirring to obtain the polyarylether-based polymer with side chain in polyethylene glycol structure. The all-solid polymer electrolyte prepared by the present invention has favorable ionic conductivity and excellent heat resistance, high temperature resistance and mechanical strength.

A polyarylether-based polymer with side chain in polyethylene glycol structure, a solid polymer electrolyte and preparation methods therefor are disclosed. The main chain of the polymer has a polymer structure containing a polyarylether group, the side chain has a polyethylene glycol structure, and the structural formula of the polyarylether-based polymer is as follows:

##STR00001##

and the preparation method for the polyarylether-based polymer with side chain in polyethylene glycol structure comprises: step (1): preparing a polymer containing a polyarylether group; and step (2): dissolving the polymer containing a polyarylether group and polyethylene glycol in a solvent, then adding a catalyst, dripping a coupling agent after the catalyst is dissolved, and conducting reaction while stirring to obtain the polyarylether-based polymer with side chain in polyethylene glycol structure. The all-solid polymer electrolyte prepared by the present invention has favorable ionic conductivity and excellent heat resistance, high temperature resistance and mechanical strength.

A compound represented by the formula (1) is described, which has a linear polysiloxane structure at the end, a polymerizable group at the other end, and a polyether group or a hydrophilic group as a side chain bounded to a linking group which is represented by -(L.sup.1).sub.a-CH-L.sup.2- in the formula (1) and exists between the polysiloxane structure and the terminal polymerizable group. The compound has excellent compatibility with a hydrophilic monomer, and the surface wettability of hydrogel obtained from the compound as a monomer is improved. Methods are also described for preparing the polysiloxane monomer compound, a polymer having a repeating unit derived from the polymerization at the (meth)acryl group of the polysiloxane monomer compound, and an ophthalmic device containing the polymer.